Back

Analysis of the effect of therapy on exercise capacity in patients with Fabry disease

11 May 2026 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: Contemporary challenges in cardiomyopathies Renal Failure and Cardiovascular Disease HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Alessandra Cuomo

University of Naples Federico II, Naples (Italy)

5 More presentations in this session

Presentation thumbnail
AAV gene therapies for inherited cardiomyopathies
Doctor E. Nicoletti
Abstract Slides
Presentation thumbnail
Association of peak cardiac troponin with prognosis of immune checkpoint inhibitor associated myocarditis
Doctor M. Ono (Kobe, JP)
Abstract Slides
Presentation thumbnail
Pregnancy outcomes in women with complex CHD, mWHO III and IV
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Body mass index extremes association with worsened disease and clinical outcomes in patients with hypertrophic cardiomyopathy
Doctor R. Montalvao (Lisboa, PT)
Abstract Slides
Presentation thumbnail
Genetic variants identify patients with myocarditis at higher risk for ICD implantation
Ms B. Hariharan (Toronto, CA)
Abstract Slides

Access the full session

Session thumbnail
Contemporary challenges in cardiomyopathies

The Event

Event poster

Heart Failure 2026

11 May 2026 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Changes in peak oxygen consumption on excercise and cardiomyopathy disease stage in Fabry disease
1 September 2024
thumbnail
Congress Presentation
High-sensitivity troponin T as a biomarker of exercise tolerance impairment assessed in CPET and left ventricular function 3 months after adjuvant therapy for breast cancer
20 June 2025
thumbnail
Congress Presentation
functional capacity assessment of cardiac amyloidosis patients before treatment and rehabilitation
13 June 2025
thumbnail
Congress Presentation
Effects of aerobic physical rehabilitation on muscle fiber metabolism in patients with severe heart failure
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources